# REDHILL BIOPHARMA LTD (RDHLXXXX)

> Institutional ownership reported to the SEC as of Q3 2024, from Form 13F filings. Source: https://holderbook.com/stocks/RDHLXXXX/

- Reporting holders: 1
- Reported value: $2
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $2 | 7 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2024 | 1 | $2 |
| Q2 2024 | 17 | $719.7K |
| Q1 2024 | 16 | $1.4M |
| Q4 2023 | 19 | $473.5K |
| Q3 2023 | 20 | $790.4K |
| Q2 2023 | 21 | $439.4K |
| Q1 2023 | 18 | $1.3M |
| Q4 2022 | 40 | $1.5M |
| Q3 2022 | 39 | $1.5M |
| Q2 2022 | 47 | $4.0M |
| Q1 2022 | 45 | $12.4M |
| Q4 2021 | 53 | $15.3M |